NASDAQ:NRSN

NeuroSense Therapeutics Ltd. Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology

$0.85

+0.0008 (+0.0947%)

At Close: Jun 25, 2024

NeuroSense Therapeutics Ltd. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 NRSN shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC ... NRSN Profile

Golden Star

Ticker	Date	Change	Price
ANGL	Jun 20	0.0350%	$28.57
BRK-A	Jun 20	0.575%	$617,249.90
EPD	Jun 18	2.90%	$28.30
USFD	Jun 18	4.33%	$53.14
UFPT	Jun 18	2.69%	$253.79
^DJI	Jun 18	1.48%	38,834.86 points
SARK	Jun 17	2.34%	$30.34
RGA	Jun 17	1.53%	$203.90
MA	Jun 17	1.68%	$448.11
BR	Jun 17	1.44%	$197.65

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In